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Abstract 
The present article focuses on the properties and indications of scaffold-based extracellular matrix 
technologies as alternatives to autogenous soft tissue grafts for periodontal and peri-implant plastic 
surgical reconstruction. The different processing methods for the creation of cell-free constructs 
resulting in preservation of the extracellular matrices influence the characteristics and behavior of 
scaffolding biomaterials. The aim of this review is to discuss the properties, clinical application and 
limitations of extracellular matrix-based scaffold technologies in periodontal and peri-implant soft 
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Scaffold constructs for soft tissue augmentation 
Biomaterials have progressively gained popularity in periodontics due to their advantages compared 
to autogenous grafts, such as unrestricted availability, avoidance of a secondary surgical site, 
reduction of the surgical time, and patient’s preference 1. Indeed, the risk of developing 
moderate/severe post-operative swelling and pain increased at 3% and 4%, respectively for each 
minute of the surgical procedure 2. Ideally, biomaterials should be characterized by certain 
properties, including biocompatibility, ease in surgical site adaptation and positioning, space 
maintenance, clot stabilization, tissue-integration, cell invasion/guidance, and promotion of cellular 
proliferation 3. Based on their origin, scaffolds can be classified as allogenic, xenogeneic, alloplastic, 
and living constructs (when they include cells). This review aims to present the characteristics, 
clinical application, and limitations of extracellular matrix-based technologies in periodontal and 
peri-implant soft tissue augmentation.  
 
Natural and cadaveric scaffolds  
Decellularized Human Dermis 
Acellular dermal matrix (ADM) is a soft tissue graft obtained from human skin that has undergone a 
decellularization process 4, 5. Devoid of epithelium and cellular components, the preserved 
extracellular matrix (ECM) serves as a scaffold that promotes cellular migration and revascularization 
from the surrounding host tissues 4-7. 
First introduced for the treatment of burn wounds 8, the ADM has been extensively used in several 
other indications, such as facial augmentation, dural replacement, breast reconstruction and 
esthetic plastic surgery 4, 9, 10. In dentistry, ADM was firstly evaluated for increasing attached and/or 
keratinized gingivae11. However, the ADM clinical outcomes are inferior to the free gingival graft 12, 
13. In particular, the ADM seems to be more prone to shrinkage, which may also explain the less 
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tissue thickness observed 5, 13. Histological data of sites treated with ADM show a “scar” tissue 
appearance 6, although better esthetic and color match with the surrounding tissue has been 
described, when compared to a free gingival graft (FGG) 5, 6, 13. 
Currently, the ADM is more routinely used for root coverage procedures (Figure 1) and soft tissue 
augmentation at tooth or implant sites (Figure 2) 14-19, particularly when avoiding a second surgical 
site and minimizing patient morbidity is the primary concern 17, 20, 21. Although ADM is considered to 
be the graft substitute with the most similar outcomes to the connective tissue graft (CTG) 22, a 
recent network meta-analysis evaluating the changes in root coverage outcomes over time showed 
that only CTG-treated sites had a trend towards the stability of the gingival margin among the other 
root coverage techniques 19. Similarly, a 12-year follow-up study reported a significant relapse of the 
gingival margin in multiple gingival recession treated with ADM 17.  A possible mechanism may be 
that the ADM may not have the capability of inducing keratinization of the overlying epithelia 5, 7, 13, 
which seems to be a positive predictor for the stability of the gingival margin 17, 19, 23, 24. It can be 
suggested that with the treatment of ADM, similar root coverage outcomes to CTG can be obtained 
in the presence of a distinct amount of keratinized tissue width at baseline (≥ 2 mm17).  
Various human-derived ADMs are currently available, including AlloDerm **, Puros Dermis ††, 
and Allopatch ‡‡. Allopatch is derived from the human fascia lata from the American Association of 
Tissue Banks. This allograft is minimally processed, which may better preserve the biomechanical 
and biochemical properties of the allograft. It has been suggested that several properties should be 
considered when choosing the graft, including tissue origin, processing methods, cross linking and 
biomechanical properties 25, and that the different procedures to obtain human allografts may 
influence scaffold characteristics, such as cell penetration and proliferations 26, 27. Kuo et al. 
compared ADM to Allopatch as scaffolds supporting cellular ingrowth in fabricating tissue 
engineered grafts (TEGs) 27. They observed different properties between the allografts, suggesting 
that decellularization protocols can affect the scaffold biological and physical characteristics 27. 
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Increased vascular invasion into the constructs were found for TEGs based on Allopatch compared to 
those including ADM. However, ADM-based TEGs showed more rapid cellular migration 27.  
 
Human amniotic membrane 
Human amniotic membrane (HAM) is the innermost fetal membrane lining the amniotic cavity (0.02-
0.05 mm in thickness) which derives from healthy maternal donors during an elective Caesarian 
section 28. All donors’ serum samples are tested to ensure the absence of viruses and all serologic 
tests are also repeated 6 months later 29. HAM undergoes a process of preparation and preservation, 
such as cryopreservation and glycerol preservation or lyophilization and gamma irradiation 30, 
resulting in the elimination of the cellular component while preserving the matrix 31, 32. HAM is 
composed by a single epithelial layer, a thick basement membrane, and an avascular collagen layer 
28, 30. The avascular stroma contains several growth factors, including epidermal growth factor (EGF), 
transforming growth factors alpha and beta (TGF-, TGF-), fibroblast growth factor-2 (FGF-2), and 
keratinocyte growth factor (KGF) 29, 33. These growth factors contribute to the anti-inflammatory, 
immunomodulatory, antimicrobial, antiviral, anti-scarring and analgesic properties 28, 30, 34, 35. In 
addition, it has been reported that HAM promotes epithelial wound healing, angiogenesis and ECM 
deposition 28, 30, 34, 35. Because of these properties, HAM has been used in several fields for the 
promotion of wound repair and regeneration 30, 36. In periodontics, it has been investigated for 
application in guided tissue regeneration 36 and in the treatment of gingival recessions 28. In a 
randomized controlled study, it was confirmed that cryopreserved amniotic membrane was effective 
in enhancing cicatrization, wound healing and reducing pain in patients undergoing implant 
placement 29. Disadvantages of this allograft includes difficulty in handling, rapid degradation and 
the lack of adherence in full-thickness burns where HAM acts as a temporary wound dressing 37. 
HAM is commercially available as BioXclude §§. 
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Xenogeneic collagen matrices 
Bilayered collagen matrix 
The Mucograft ǁǁ is a non-cross-linked, resorbable, porcine bilayered collagen matrix (CM) 
composed of collagen types I and III 38, 39. CM presents an occlusive compact layer of dense collagen, 
and smooth texture aiming at promoting cell adhesion and a porous structure facing the host tissue 
that enhances tissue integration and angiogenesis 39-41. The compact layer, made from porcine 
peritoneum, acts as a barrier and provides stability, while the porous layer, obtained from the 
porcine skin, is designed for supporting blood clot stabilization and the promotion of cellular 
ingrowth 39. 
These properties demonstrate the potential clinical applications of the biomaterial in periodontal 
plastic surgical procedures, where CM has been used to increase keratinized tissue, cover single- and 
multiple- gingival recession(s) and augment soft tissue thickness 41-43. Among its main advantages are 
the reduced surgical time and patient morbidity compared to autogenous soft tissue grafts 41, 42. 
Clinical trials have shown that CM is able to increase the keratinized tissue width 41, 44, but some have 
questioned this potential due to it lacks cellular component that are needed for keratinized tissue 
formation 45. Furthermore, the chance of root coverage procedures may also benefit from the 
addition of xenogeneic allografts 46. However, a recent randomized clinical trial did not meet the 
non-inferiority endpoint of CM compared to the “gold standard” CTG in the treatment of multiple 
gingival recessions. These findings examined odds of achieving complete root coverage, although CM 
was related to a shortened surgical and recovery time 42.   
An excellent color match with the surrounding tissue was reported when CM was used in soft tissue 
augmentation 39, 40. This result may be due to the properties of CM that acts as a scaffold matrix, 
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accelerating migration of cells from adjacent tissues and at the same time as a protective dressing 
when left exposed 41, 47. 
Histological data has confirmed the good integration of CM in the host tissues without signs of 
adverse tissue reaction, or evidence of a significant inflammatory response 38, 40, 48. Therefore, 
collagen matrices have also been proposed as scaffolds for supporting the proliferation of fibroblasts 
and keratinocytes in TEGs 49, 50. 
 
Volume-stable collagen matrix  
A new porcine, porous, collagen matrix (Fibrogide)ǁǁ has recently been introduced for soft tissue 
regeneration. This graft has also been called volume-stable collagen matrix (VCMX) since one of its 
main advantages is the ability to maintain a good volume stability 51, 52. VCMX is made of collagen 
and undergoes a cross-linking providing volume stability and some elasticity at the same time 51-53. 
VCMX has only one, porous, layer that promotes angiogenesis, ingrowth of fibroblasts, matrix 
biosynthesis, and tissue integration 51, 52, 54. In contrast to CM that has been used also in an open 
environment, VCMX requires a submerged healing 52, 55. Several preclinical and clinical studies 
investigating VMCX showed promising results in terms of volume gain, without any significant 
adverse reactions noted 52, 55-57 (Figure 3). Further studies with longer follow-up are needed to 
confirm these early findings of VCMX (especially compared to CTG) in increasing mucosal thickness 
at implant sites. 
 
Xenogeneic acellular dermal matrix  
Porcine-derived acellular dermal matrix (PADM: Mucoderm) ¶¶ is a collagen matrix obtained from 
porcine dermis after a multi-step process aimed at removing all the antigenic components 58, 59. 
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Therefore, PADM serves as a three-dimensional matrix, promoting the proliferation of fibroblasts 
and endothelial cells and supporting a fast revascularization of its structure 58, 60. The use of PADM 
has been suggested as a carrier for enamel matrix derivatives in the treatment of gingival recessions 
59, where histological evidence of periodontal regeneration was observed 59. Figure 4 showed two 
clinical cases in which PADM was used for the treatment of soft tissue deficiencies at tooth and 
implant sites.  
 
Extracellular matrix 
The DynaMatrix ## is a three-dimensional structure porcine-derived matrix from the submucosa of 
the small intestine in a cell-free procurement, while the natural composition of the matrix molecules 
is preserved 61, 62. The matrix provides a scaffold that promotes the repopulation of fibroblasts, blood 
vessels and epithelium from the adjacent tissues 62. In vitro studies showed its favorable properties 
in stimulating cellular adhesion, differentiation and proliferation 63, 64 as well as in facilitating 
angiogenesis 65. These characteristics may explain the clinical outcomes of this matrix that was found 
to be effective and predictable in keratinized gingiva augmentation and in resembling the 
surrounding tissue 62.  
 
Although these extracellular matrix-based scaffolds have been proposed as an alternative to an 
autogenous graft, clinical considerations regarding their handling characteristics and stabilization 
compared to free gingival – and connective tissue graft is lacking in the literature. The clinical 
experience of the authors suggests that the use of these graft substitutes poses additional 
challenges for suturing the material on the recipient bed or for inserting it into a tunnel flap. It has 
been reported that one of the advantages of the VCMX compared to CM is the propriety of regains 
its initial volume within few minutes, due to its high elasticity 52. Nevertheless, also VCMX seems to 
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be less resistant to compression than connective tissue graft which can be easily stabilized to the de-
epithelialized papilla or inserted into the tunnel flap with sutures. In the future, there should be 
greater studies on the material handling characteristics to optimize placement during surgery. 
 
Polymeric matrices 
Polymeric matrices have been widely used as biomaterials in tissue engineering for fabricating 
scaffolds and medical devices. Natural polymers can be derived from: i) proteins, including collagen, 
silk, gelatin and fibrin glue; ii) polysaccharides, such as hyaluronic acid and chitosan; and iii) 
polynucleotides 66. Additionally, the manufacturing methods of natural and synthetic biomaterials 
include many processes, such as electrospinning, 3D printing or the use of CAD/CAM. Natural 
polymers were among the first biomaterials investigated in dental tissue engineering and, among 
their main advantages, a greater biocompatibility and interaction with host cells compared to 
synthetic matrices have been described 66. Because of its properties of promoting wound healing, 
silk has been widely used as a scaffold in soft- and bone tissue engineering in combination with 
epidermal or mesenchymal stem cells or fibroblasts 67, 68. Collagen is the most abundant naturally-
derived protein in the human body and it’s the major protein of the ECM of the skin dermal layer 67. 
Several collagen-based grafts have been proposed in wound healing and tissue engineering of skin, 
including ADM, cellular epidermis/dermis and bilayered skin equivalents 67. The lack of biostability 
and frequent wound contracture are among the disadvantages of collagen-based scaffolds. 67 These 
limitations have been overcome by cross-linking the collagen matrices or by combining them with 
other ECM molecules 67, 69.  
Synthetic materials have progressively become widely used in the biomedical field since they can be 
tailored for attaining different desired characteristics using various fabrication techniques 66, 67. 
Compared to natural polymers, synthetic scaffolds are produced in large quantities and have a 
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longer shelf life. In addition, they show consistent properties, such as tensile strength, elastic 
modulus and degradation rate 66. However, lack of cellular recognition, biocompatibility and 
biodegradability represent their main drawbacks that may limit its clinic application 66. Given these 
shortcomings, synthetic biomaterials are usually used in combination with natural polymers 67, 70. 
Polycaprolactone (PCL), poly(lactic acid) or polylactic acid or polylactide (PLA), and poly(lactic-co-
glycolic) acid (PLGA) are among the most used synthetic polymers in tissue engineering, specifically 
with bone regeneration 66, 71. PLGA is a versatile polymer that can be personalized to any shape and 
size while controlling its degradation time to match the rate of the tissue neogenesis or the desired 
drug release profile. This material has been used as a scaffold for tissue regeneration or as a drug 
delivery system, in particular as nano-/micro-particles of PLGA that are able to control the delivery 
of growth factors for tissue engineering applications 72, 73. Nevertheless, there is limited evidence 
available on the use of synthetic biomaterials for soft tissue reconstruction in humans. Table 1 




Extracellular-based scaffolding technologies are effective in soft tissue augmentation at periodontal 
and peri-implant sites. Given that these materials are devoid of cells and usually cellular signaling 
molecules, they promote soft tissue volume, but not keratinized tissue neogenesis. Nevertheless, 
ECM scaffold constructs generally encourage the migration and the proliferation of fibroblasts and 
keratinocytes providing an excellent color match with the surrounding tissue. The reduced surgical 
time and morbidity compared to autogenous grafts is one of the main advantages of these materials 
as patient preferences indicate. The use of synthetic scaffolds made from polymeric biomaterials 
such as PCL, PLGA, and PLLA have shown good potential for combination drug delivery approaches, 
however as stand-alone technologies they do not promote new tissue formation or stimulate cellular 
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and vascular ingrowth critical for clinical success. Future research continues to examine combination 
biologic and/or cell-based ECM constructs for clinical application to improve treatment outcomes. 
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Figures Legend 
Figure 1. A-F) Coronally advanced flap and acellular dermal matrix for the treatment of an isolated 
gingival recession. A) Pre-operative gingival recession on the left maxillary canine; B) Flap design and 
elevation; C) Acellular dermal matrix adapted and sutured over the root; D) Flap coronally advanced 
and sutured; E) 6-months result; F) The complete root coverage is maintained also at the 10-year 
recall. G-L) Tunnel technique and acellular dermal matrix used for the treatment of multiple adjacent 
gingival recessions. G) Clinical scenario at baseline; H) tunnel flap is performed; I) acellular dermal 
matrix is inserted in the flap; J) the flap is sutured together with the graft material in a coronally 
advanced position; K) 2-week post-op; L) 6-months result showing the complete root coverage of the 
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Figure 2. Acellular dermal matrix used for soft tissue augmentation in a maxillary dental implant 
lacking buccal bone. A) Clinical scenario before bone augmentation; B) 6-months after guided bone 
regeneration; C-D) soft tissue augmentation by using an acellular dermal matrix; E) flap closure; F) 5-
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Figure 3. Volume-stable collagen matrix around teeth used for root coverage purposes. A) Gingival 
recession defect on a maxillary canine; B) A split-full-split flap limited to the canine was performed; 
C) After the de-epithelialization of the anatomical papillae, a volume-stable collagen matrix was 
applied on the root surface and sutured to the de-epithelialized papillae; D) The flap was coronally 
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Figure 4. Xenogeneic acellular dermal matrix used for the treatment of multiple adjacent gingival 
recessions (A-E) and for soft tissue augmentation at a single implant site (F-K). A) Multiple adjacent 
maxillary gingival recessions; B-C) After the split-full-split envelope flap preparation, a xenogeneic 
acellular dermal matrix was inserted and stabilized over the roots; D) Flap closure; E) 1-year 
outcomes; F) Dental implant presenting with inadequate soft tissue thickness and poor esthetics; G-
H) xenogeneic acellular dermal matrix sutured around the implant; I) Flap closure; J-K) 1-year 
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Table 1. Summary of the extracellular matrix- based scaffolds used in periodontal and peri-implant soft tissue reconstruction 











 Promotes cellular 
migration and 
revascularization from the 
host tissues 
 Minimal patient morbidity  
 Root coverage 
 Increasing tissue 
thickness  
 Increasing 




A Scarano et al. 
2009, Wang et al. 
2014, Hutton et 












anti-scarring and analgesic 
properties 
 Promotes epithelial wound 
healing, angiogenesis and 
extracellular matrix 
deposition 
 Root coverage 
 





C Velez et al. 2010, 
Kiany et al. 2015, 
Jain et al. 2017 28, 
29, 36  
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Bilayer collagen 
matrix 
Porcine  One layer promotes cell 
adhesion, and enhances 
tissue integration and 
angiogenesis, while the 
other acts as a barrier and 
provides stability 
 Excellent color match with 
the adjacent tissue 
 Lower morbidity then 
autogenous grafts 
 Root coverage 
 Increasing tissue 
thickness 
 Increasing 




A Sanz et al. 2009,  
Lorenzo et al. 
2012, Cairo et al. 
2017, Tonetti et 
al. 2018 41-44 
Volume-stable 
collagen matrix 
Porcine  Maintenance of a good 
volume stability 
 Promotes angiogenesis 
and ingrowth of fibroblasts 
 Root coverage 
 Increasing tissue 
thickness 
 Increasing 




B Thoma et al. 
2016, 2017, 
Zeltner et al. 








 Root coverage 
 Increasing tissue 
thickness 
 B Shirikata et al. 








 Promotes the 
repopulation of 
fibroblasts, blood vessels 
and epithelium from the 
adjacent tissues 






positioned flap   
 C Nevins et al. 
2010 62 
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Legend. SORT: Strength-of-Recommendation Taxonomy. SORT A: consistent, good-quality patient-oriented evidence; SORT B: inconsistent or limited-quality 
patient-oriented evidence; SORT-C: consensus, disease-oriented evidence, usual practice, expert opinion or case series for studies of diagnosis, treatment, 
prevention, or screening 74 
 
 
and proliferation 
